Lamzede

velmanase alfa-tycv

Approval

ApplicationBLA 761278
Approval dateFeb 16, 2023
Approval year2023
SponsorChiesi Farmaceutici SPA

FDA-approved use

To treat non-central nervous system manifestations of alpha-mannosidosis

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Lamzede: